[
  {
    "ts": null,
    "headline": "Medtronic Stock Rises After Earnings. What Caught Investors’ Attention.",
    "summary": "Medtronic  posted fiscal second-quarter earnings and revenue that broadly beat analysts’ expectations and the company hiked its fiscal 2026 guidance.  The medical technology company reported adjusted earnings of $1.36 a share, topping Wall Street’s calls for $1.31, while sales of $8.96 billion beat the $8.87 billion consensus among analysts polled by FactSet.  The company recorded its strongest cardiovascular revenue growth in over a decade, excluding the pandemic.",
    "url": "https://finnhub.io/api/news?id=27296a47541ebd5340dd604687badfe8048befa679eefcf08e4d3882cf3d3e68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763467260,
      "headline": "Medtronic Stock Rises After Earnings. What Caught Investors’ Attention.",
      "id": 137538360,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "FDS",
      "source": "Yahoo",
      "summary": "Medtronic  posted fiscal second-quarter earnings and revenue that broadly beat analysts’ expectations and the company hiked its fiscal 2026 guidance.  The medical technology company reported adjusted earnings of $1.36 a share, topping Wall Street’s calls for $1.31, while sales of $8.96 billion beat the $8.87 billion consensus among analysts polled by FactSet.  The company recorded its strongest cardiovascular revenue growth in over a decade, excluding the pandemic.",
      "url": "https://finnhub.io/api/news?id=27296a47541ebd5340dd604687badfe8048befa679eefcf08e4d3882cf3d3e68"
    }
  }
]